Switzerland· 69257001
Elfabrio
A pegunigalsidase alfa product containing pegunigalsidasum alfa, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Pegunigalsidase alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB20 (pegunigalsidase alfa), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Pegunigalsidase alfa · ATC A16AB20
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- pegunigalsidasum alfa
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- A16AB20
- ATC class
- Pegunigalsidase alfa
- Defined daily dose
- 5 mg, P
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680692570017Vial 10 mlCHF 2043.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pegunigalsidase alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainELFABRIO 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONChiesi Farmaceutici S.P.A.
- IcelandElfabrioChiesi Farmaceutici S.p.A.*
- CzechiaELFABRIOChiesi Farmaceutici S.p.A., Parma
- BelgiumElfabrio 2 mg/mlChiesi Farmaceutici
- FinlandElfabrioChiesi Farmaceutici S.p.A.
- United KingdomElfabrio 20mg/10ml concentrate for solution for infusion vialsChiesi Ltd
- United StatesELFABRIOChiesi USA, Inc.
- IrelandElfabrio 2 mg/ml Concentrate for solution for infusionChiesi Farmaceutici S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elfabrio
- Liechtenstein · Elfabrio
- Norway · Elfabrio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31115a1b-9385-43ac-92d4-7df63e75d40b GET /v1/drugs/31115a1b-9385-43ac-92d4-7df63e75d40b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "pegunigalsidasum alfa 20 mg",
"valid_from": "2024-02-01",
"limitations": null,
"galenic_form": "Inf Konz 20 mg/10ml",
"therapeutic_area": null,
"sl_inclusion_date": "2024-02-01",
"self_retention_pct": 10
}See everything about pegunigalsidase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.